J&J Medical Connect
CAPLYTA®

(lumateperone)

J&J Medical Connect

Connect with us

  • Products

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

CAPLYTA® (lumateperone)
Medical Information

CAPLYTA- Dosing - Abrupt Discontinuation or Withdrawal

Last Updated: 03/17/2026

SUMMARY  

  • There are currently no recommendations for dose tapering in the event that treatment with CAPLYTA is discontinued.

Literature Search

A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, and DERWENT® (and/or other resources, including internal/external databases) conducted on 24 September 2025 did not identify any relevant citations pertaining to this topic.